Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Diazepam. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 8/20 | 0.60 |
| ▸ | GABRA5 known ✓ | P31644 | 8/20 | 0.60 |
| ▸ | GABRA3 known ✓ | P34903 | 8/20 | 0.60 |
| ▸ | GABRA2 known ✓ | P47869 | 8/20 | 0.60 |
| ▸ | GABRB2 known ✓ | P47870 | 7/20 | 0.60 |
| ▸ | GABRG2 known ✓ | P18507 | 6/20 | 0.60 |
| ▸ | GABRB3 known ✓ | P28472 | 6/20 | 0.60 |
| ▸ | GABRP known ✓ | O00591 | 3/20 | 0.60 |
| ▸ | GABRD known ✓ | O14764 | 3/20 | 0.60 |
| ▸ | GABRB1 known ✓ | P18505 | 3/20 | 0.60 |
| ▸ | GABRA4 known ✓ | P48169 | 3/20 | 0.60 |
| ▸ | GABRE known ✓ | P78334 | 3/20 | 0.60 |
| ▸ | GABRA6 known ✓ | Q16445 | 3/20 | 0.60 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 3/20 | 0.60 |
| ▸ | GABRG3 known ✓ | Q99928 | 3/20 | 0.60 |
| ▸ | GABRQ known ✓ | Q9UN88 | 3/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.60 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.60 |
| ▸ | ALB | P02768 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diazepam SCHEMBL10351230 | 0.92 | ADRA1A (0.54) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| Lorazepam SCHEMBL4978513 | 0.89 | ADRA1A (0.51) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| Diazepam SCHEMBL8931438 | 0.87 | GABRA1 (0.79) | GABRA1GABRA5GABRA3GABRA2GABRB2 | |
| Diazepam SCHEMBL6823824 | 0.87 | GABRA1 (0.79) | GABRA1GABRA5GABRA3GABRA2GABRB2 | |
| Alprazolam SCHEMBL3664716 | 0.86 | GABRA1 (0.66) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| Clobazam SCHEMBL28086348 | 0.85 | ADRA1A (0.61) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| Adinazolam SCHEMBL28086683 | 0.83 | OPRK1 (0.63) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| Diazepam SCHEMBL1003950 | 0.82 | GABRA1 (0.70) | ADRA1AGABRA1GABRA5GABRA3GABRA2 | |
| SCHEMBL16922124 | 0.82 | GABRA1 (0.70) | GABRA1GABRA5GABRA3GABRA2GABRB2 | |
| SCHEMBL20369049 | 0.82 | GABRA1 (0.70) | ADRA1AGABRA1GABRA5GABRA3GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0952820-A1 | PROCESS FOR THE MANUFACTURE OF A PULVEROUS PREPARATION | F. HOFFMANN-LA ROCHE AG (CH) | 1999-11-03 | — | — | EP | disclosed |
| WO-1998016204-A1 | PROCESS FOR THE MANUFACTURE OF A PULVEROUS PREPARATION | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-23 | — | — | WO | disclosed |